165 related articles for article (PubMed ID: 33059604)
1. Detection of MCM5 as a novel non-invasive aid for the diagnosis of endometrial and ovarian tumours.
Stockley J; Akhand R; Kennedy A; Nyberg C; Crosbie EJ; Edmondson RJ
BMC Cancer; 2020 Oct; 20(1):1000. PubMed ID: 33059604
[TBL] [Abstract][Full Text] [Related]
2. Minichromosomal Maintenance Component Complex 5 (MCM5) as a Marker of Barrett's Esophagus-Related Neoplasia: A Feasibility Study.
Everson M; Magee C; Alzoubaidi D; Brogden S; Graham D; Lovat LB; Novelli M; Haidry R
Dig Dis Sci; 2019 Oct; 64(10):2815-2822. PubMed ID: 30982210
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study.
Záveský L; Jandáková E; Turyna R; Langmeierová L; Weinberger V; Záveská Drábková L; Hůlková M; Hořínek A; Dušková D; Feyereisl J; Minář L; Kohoutová M
Pathol Oncol Res; 2015 Sep; 21(4):1027-35. PubMed ID: 25827090
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments.
Stoeber K; Swinn R; Prevost AT; de Clive-Lowe P; Halsall I; Dilworth SM; Marr J; Turner WH; Bullock N; Doble A; Hales CN; Williams GH
J Natl Cancer Inst; 2002 Jul; 94(14):1071-9. PubMed ID: 12122098
[TBL] [Abstract][Full Text] [Related]
5. Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer.
Hanžek A; Siatka C; Duc AE
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7981-7993. PubMed ID: 36914786
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of urinary bladder urothelial carcinoma by immunocytology with p53, MCM5, MCM2 and Ki-67 antibodies using cell blocks derived from urine.
Brisuda A; Háček J; Čechová M; Škapa P; Babjuk M
Cytopathology; 2019 Sep; 30(5):510-518. PubMed ID: 30943322
[TBL] [Abstract][Full Text] [Related]
7. Detection of endometrial cancer using tampon-based collection and methylated DNA markers.
Bakkum-Gamez JN; Sherman ME; Slettedahl SW; Mahoney DW; Lemens MA; Laughlin-Tommaso SK; Hopkins MR; VanOosten A; Shridhar V; Staub JK; Cao X; Foote PH; Clarke MA; Burger KN; Berger CK; O'Connell MC; Doering KA; Podratz KC; DeStephano CC; Schoolmeester JK; Kerr SE; Wentzensen N; Taylor WR; Kisiel JB
Gynecol Oncol; 2023 Jul; 174():11-20. PubMed ID: 37141817
[TBL] [Abstract][Full Text] [Related]
8. Potential of mid-infrared spectroscopy as a non-invasive diagnostic test in urine for endometrial or ovarian cancer.
Paraskevaidi M; Morais CLM; Lima KMG; Ashton KM; Stringfellow HF; Martin-Hirsch PL; Martin FL
Analyst; 2018 Jun; 143(13):3156-3163. PubMed ID: 29878018
[TBL] [Abstract][Full Text] [Related]
9. HE4 as a biomarker for ovarian and endometrial cancer management.
Li J; Dowdy S; Tipton T; Podratz K; Lu WG; Xie X; Jiang SW
Expert Rev Mol Diagn; 2009 Sep; 9(6):555-66. PubMed ID: 19732003
[TBL] [Abstract][Full Text] [Related]
10. Combining copy number, methylation markers, and mutations as a panel for endometrial cancer detection via intravaginal tampon collection.
Sangtani A; Wang C; Weaver A; Hoppman NL; Kerr SE; Abyzov A; Shridhar V; Staub J; Kocher JA; Voss JS; Podratz KC; Wentzensen N; Kisiel JB; Sherman ME; Bakkum-Gamez JN
Gynecol Oncol; 2020 Feb; 156(2):387-392. PubMed ID: 31787246
[TBL] [Abstract][Full Text] [Related]
11. LyGDI is a promising biomarker for ovarian cancer.
Zhen H; Yang S; Wu H; Wang S; Lv J; Ma L; Zhang X
Int J Gynecol Cancer; 2010 Apr; 20(3):316-22. PubMed ID: 20375790
[TBL] [Abstract][Full Text] [Related]
12. Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons.
Bakkum-Gamez JN; Wentzensen N; Maurer MJ; Hawthorne KM; Voss JS; Kroneman TN; Famuyide AO; Clayton AC; Halling KC; Kerr SE; Cliby WA; Dowdy SC; Kipp BR; Mariani A; Oberg AL; Podratz KC; Shridhar V; Sherman ME
Gynecol Oncol; 2015 Apr; 137(1):14-22. PubMed ID: 25677060
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive detection of endometrial cancer by DNA methylation analysis in urine.
van den Helder R; Wever BMM; van Trommel NE; van Splunter AP; Mom CH; Kasius JC; Bleeker MCG; Steenbergen RDM
Clin Epigenetics; 2020 Nov; 12(1):165. PubMed ID: 33143739
[TBL] [Abstract][Full Text] [Related]
14. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.
Chang CC; Wang HC; Liao YP; Chen YC; Weng YC; Yu MH; Lai HC
J Gynecol Oncol; 2018 Jan; 29(1):e17. PubMed ID: 29185275
[TBL] [Abstract][Full Text] [Related]
15. Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers.
Zavesky L; Jandakova E; Turyna R; Langmeierova L; Weinberger V; Minar L
Neoplasma; 2016; 63(1):121-32. PubMed ID: 26639242
[TBL] [Abstract][Full Text] [Related]
16. Fourier-transform infrared spectroscopy coupled with a classification machine for the analysis of blood plasma or serum: a novel diagnostic approach for ovarian cancer.
Gajjar K; Trevisan J; Owens G; Keating PJ; Wood NJ; Stringfellow HF; Martin-Hirsch PL; Martin FL
Analyst; 2013 Jul; 138(14):3917-26. PubMed ID: 23325355
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers.
Wang Y; Li L; Douville C; Cohen JD; Yen TT; Kinde I; Sundfelt K; Kjær SK; Hruban RH; Shih IM; Wang TL; Kurman RJ; Springer S; Ptak J; Popoli M; Schaefer J; Silliman N; Dobbyn L; Tanner EJ; Angarita A; Lycke M; Jochumsen K; Afsari B; Danilova L; Levine DA; Jardon K; Zeng X; Arseneau J; Fu L; Diaz LA; Karchin R; Tomasetti C; Kinzler KW; Vogelstein B; Fader AN; Gilbert L; Papadopoulos N
Sci Transl Med; 2018 Mar; 10(433):. PubMed ID: 29563323
[TBL] [Abstract][Full Text] [Related]
18. Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial.
Tarney CM; Wang G; Bateman NW; Conrads KA; Zhou M; Hood BL; Loffredo J; Tian C; Darcy KM; Hamilton CA; Casablanca Y; Lokshin A; Conrads TP; Maxwell GL
Am J Obstet Gynecol; 2019 Nov; 221(5):472.e1-472.e10. PubMed ID: 31279844
[TBL] [Abstract][Full Text] [Related]
19. Application of SELDI-TOF in N-glycopeptides profiling of the urine from patients with endometrial, ovarian and cervical cancer.
Mu AK; Lim BK; Aminudin N; Hashim OH; Shuib AS
Arch Physiol Biochem; 2016 Jul; 122(3):111-6. PubMed ID: 26849673
[TBL] [Abstract][Full Text] [Related]
20. Detection of endometrial cancer in cervico-vaginal fluid and blood plasma: leveraging proteomics and machine learning for biomarker discovery.
Njoku K; Pierce A; Chiasserini D; Geary B; Campbell AE; Kelsall J; Reed R; Geifman N; Whetton AD; Crosbie EJ
EBioMedicine; 2024 Apr; 102():105064. PubMed ID: 38513301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
